Moderna Inc (MRNA) Q4 2022 Earnings Call Transcript
Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief...
Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief...
Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due...
Medtronic PLC (NYSE: MDT) Q3 2023 earnings call dated Feb. 21, 2023 Corporate Participants: Ryan Weispfenning — Vice President and Head of...
Medtronic plc (NYSE: MDT) reported third quarter 2023 earnings results today. Revenue of $7.7 billion was flat as reported and up 4.1%...
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Matt Roache — Director of Investor Relations...
Sage Therapeutics Inc (NASDAQ: SAGE) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Helen Rubinstein — Director of Investor Relations...
10X Genomics Inc (NASDAQ: TXG) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Cassie Corneau — Manager, Investor Relations and...
Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke — Head of Investor Relations Christopher...
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net...
Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank — Vice President, Investor Relations Kristin...
AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for...
Ventas Inc (NYSE: VTR) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: BJ Grant — Senior Vice President-Investor Relations Debra A....
IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs — Senior Vice President – Investor...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2...
Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch — Executive Director, Investor Relations, and Corporate...
AstraZeneca PLC (NYSE: AZN) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Andy Barnett — Vice President Global Head of Investor...
Canopy Growth Corporation (TSE: WEED) Q3 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Tyler Burns — Director, Investor Relations David...
AbbVie (NYSE: ABBV) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Elizabeth Shea — Vice President, Investor Relations Richard A....
Humana AB (NYSE: HUM) Q4 2022 earnings call dated Feb. 09, 2023 Corporate Participants: Johanna Rastad — Chief Executive Officer and President...
AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net...
CVS Health Corporation (NYSE: CVS) Q4 2022 earnings call dated Feb. 08, 2023 Corporate Participants: Tom Kelly — Senior Vice President of...